felin
infecti
periton
fip
fatal
diseas
occur
domest
wild
felid
worldwid
etiolog
agent
felin
coronaviru
fcov
occur
two
distinct
pathotyp
distinguish
biolog
behavior
morpholog
author
use
differ
name
two
pathotyp
although
belong
viru
speci
felin
enter
coronaviru
fecv
highli
preval
multicat
environ
highli
cat
get
contact
fecv
fece
shed
cat
becom
infect
howev
infect
mostli
asymptomat
caus
mild
transient
diarrhea
felin
infecti
periton
viru
fipv
contrast
infecti
via
fecalor
rout
aris
mutat
avirul
fecv
within
small
percentag
infect
cat
caus
fatal
diseas
felin
infecti
periton
fip
still
unknown
exact
gene
harbor
mutat
lead
fipv
develop
sinc
promis
result
use
new
drug
treat
cat
fip
publish
recent
definit
ant
mortem
diagnosi
crucial
order
correctli
identifi
popul
cat
could
benefit
antivir
treatment
time
definit
diagnosi
challeng
sinc
exist
diagnost
test
differenti
fecv
fipv
especi
cat
without
bodi
caviti
effus
often
difficult
reach
definit
diagnosi
ant
mortem
hematolog
abnorm
common
cat
fip
report
chang
mainli
includ
anemia
nonregen
well
regen
anemia
present
eg
immunemedi
hemolyt
anemia
report
microcytosi
without
anemia
lymphopenia
commonli
cat
effus
band
neutrophilia
without
segment
neutrophilia
thrombocytopenia
wherea
microcytosi
band
neutrophilia
common
featur
fip
gener
lymphopenia
observ
cat
fip
seen
significantli
commonli
cat
effus
report
rare
cat
without
effus
vast
major
cat
fip
also
abnorm
upon
serum
biochemistri
particular
hyperproteinemia
especi
hyperglobulinemia
also
present
without
increas
total
serum
protein
hypoalbuminemia
common
cat
effus
hyperbilirubinemia
common
cat
effus
potenti
depend
organ
involv
azotemia
detect
often
cat
without
effus
increas
liver
enzym
activ
present
common
abnorm
report
hyperglobulinemia
document
cat
fip
chang
occur
variabl
combin
import
note
absolut
neither
pathognomon
specif
fip
mean
occur
cat
suffer
variou
diseas
inflammatori
basi
repres
differenti
diagnos
fip
hyperglobulinemia
cat
fip
occur
either
alon
combin
hypoalbuminemia
hyperproteinemia
although
suggest
albumin
globulin
g
ratio
better
diagnost
util
gammaglobulin
total
protein
concentr
alon
sever
cutoff
suggest
potenti
rule
rule
fip
g
ratio
hematolog
serum
biochemistri
chang
interpret
conjunct
signal
histori
laboratori
paramet
possibl
molecular
diagnost
method
elev
gammaglobulin
concentr
either
polyclon
common
monoclon
differenti
serum
protein
electrophoresi
thu
cat
present
aforement
clinicopatholog
abnorm
routin
practic
alway
interpret
conjunct
clinic
laboratori
imag
find
might
support
suspicion
fip
abnorm
consist
fip
present
well
fip
never
diagnos
sole
basi
hematolog
biochem
paramet
cat
fip
often
exhibit
markedli
increas
concentr
acut
phase
protein
app
glycoprotein
agp
serum
amyloid
saa
haptoglobin
serum
still
although
paramet
help
establish
diagnosi
neg
agp
measur
potenti
exclud
fip
pathognomon
fip
increas
concentr
app
also
found
cat
variou
inflammatori
condit
neoplasia
even
healthi
fecvinfect
cat
state
hematolog
serum
biochem
paramet
measur
app
agp
help
interpret
togeth
abnorm
order
provid
index
suspicion
fip
individu
cat
major
cat
fip
present
pleural
effus
ascit
combin
even
case
pericardi
effus
report
typic
fluid
cat
fip
viscou
strawcolor
clear
moder
cloudi
usual
form
clot
string
high
protein
content
macroscop
cytolog
examin
effus
determin
cell
count
biochem
paramet
import
order
exclud
confirm
differenti
diagnos
lymphoma
cytolog
bacteri
periton
pleuriti
cytolog
bacteri
cultur
chang
specif
fip
although
typic
effus
cat
fip
high
protein
content
low
g
ratio
rather
low
total
cell
count
find
also
occur
effus
etiolog
nevertheless
cat
present
typic
signal
clinic
routin
laboratori
abnorm
exampl
young
cat
fever
icteru
anemia
hyperglobulinemia
effus
effus
analysi
includ
cytolog
bacteri
cultur
although
complet
specif
fip
exclud
condit
could
confound
diagnosi
least
help
increas
pretest
probabl
fip
rivalta
test
cheap
quick
test
easili
perform
effus
clinic
practic
author
opinion
includ
diagnost
protocol
everi
cat
effus
good
sensit
exclud
fip
mean
whenev
neg
potenti
caus
effus
much
like
fip
therefor
especi
financi
concern
limit
number
diagnost
test
perform
rivalta
test
least
use
exclud
fip
satisfi
neg
predict
valu
advantag
need
autom
analysi
howev
specif
report
sinc
rivalta
test
posit
like
secondari
increas
amount
protein
inflammatori
mediat
fluid
origin
use
differenti
transud
exud
therefor
also
posit
effus
caus
bacteri
peritonitispleur
lymphoma
condit
howev
usual
easili
diagnos
routin
cytolog
cultur
effus
also
alway
perform
analyz
effus
sampl
anoth
test
reli
abund
protein
effus
cat
fip
measur
delta
total
nucleat
cell
count
autom
hematolog
analyz
sysmex
sysmex
europ
norderstedt
denmark
measur
leucocyt
two
differ
channel
ratio
channel
higher
cat
fip
healthi
cat
measur
show
quit
good
diagnost
accuraci
use
cutoff
diagnost
sensit
method
specif
higher
cutoff
even
increas
specif
neurolog
sign
like
occur
popul
cat
fip
without
signific
effus
csf
often
sampl
diagnost
imag
central
nervou
system
order
reach
diagnosi
upon
clinicopatholog
examin
increas
protein
content
pleocytosi
note
csf
cat
fip
csf
cytolog
often
reveal
mix
suppur
inflamm
mononuclear
infiltr
seen
well
unremark
csf
cytolog
also
occur
howev
chang
also
present
cat
neurolog
diseas
cat
neurolog
sign
caus
fip
normal
csf
analysi
eye
involv
includ
pyogranulomat
granulomat
uveiti
chorioretin
mix
uveal
inflammatori
cell
infiltr
predomin
b
lymphocyt
plasma
cell
report
cat
confirm
fip
aqueocentesi
provid
aqueou
humor
cytolog
clinicopatholog
test
howev
cytolog
often
nondiagnost
use
diagnos
lymphoma
contrast
believ
earlier
wellaccept
antibodi
test
differenti
antibodi
fecv
fipv
therefor
even
high
antibodi
titer
blood
specif
indic
fip
addit
evid
crossreact
fcov
coronavirus
tgev
canin
coronaviru
ccv
larg
proport
cat
popul
especi
multicat
household
serum
antibodi
fcov
cat
never
develop
fip
moreov
antibodi
detect
serum
cat
vaccin
fcov
signific
presenc
antibodi
diagnos
fip
individu
cat
therefor
limit
opinion
valu
antibodi
measur
diagnosi
fip
vari
base
result
numer
studi
shown
follow
paragraph
author
opinion
antibodi
measur
use
cat
suspect
fip
antibodi
measur
cat
suspect
fip
titer
determin
case
especi
low
medium
titer
zero
diagnost
valu
diagnosi
fip
although
rise
titer
sometim
detect
progress
diseas
also
seen
conjunct
fecv
reinfect
thu
indic
fip
high
rise
titer
also
found
healthi
fecvinfect
cat
never
use
confirm
suspicion
fip
likewis
neg
antibodi
test
result
exclud
fip
endstag
fip
especi
fulmin
effus
declin
antibodi
titer
possibl
sometim
antibodi
concentr
even
drop
limit
detect
approxim
cat
fip
serum
antibodi
like
immunemedi
vascul
cat
lead
extravas
blood
compon
includ
antibodi
effus
consequ
longer
detect
blood
antibodi
assay
addit
larg
number
antibodi
like
bound
high
viru
load
endstag
fip
thu
cat
fip
without
effus
neg
serum
antifcov
antibodi
titer
moreov
demonstr
longitudin
studi
healthi
cat
origin
environ
endem
fip
antibodi
titer
vari
greatli
time
therefor
measur
singl
antibodi
titer
singl
random
time
point
provid
diagnost
inform
result
studi
evalu
perform
antibodi
test
diagnos
fip
summar
tabl
sensit
specif
partial
vari
depend
antibodi
cutoff
titer
use
studi
report
diagnost
valu
antibodi
measur
compar
histopatholog
one
studi
includ
cat
fip
diagnosi
establish
upon
combin
test
perform
ant
mortem
histopatholog
anoth
studi
includ
cat
fip
suspect
clinic
diagnosi
confirm
studi
includ
control
group
consist
either
healthi
cat
andor
cat
diseas
fip
studi
fip
import
differenti
diagnosi
control
cat
state
detect
antibodi
plasma
serum
matter
titer
proof
presenc
fip
attempt
increas
specif
year
ago
antibodi
assay
develop
detect
antibodi
fcov
protein
test
design
base
erron
assumpt
fipv
fecv
contain
intact
gene
howev
test
result
better
diagnost
perform
antibodi
assay
cat
fip
fecvinfect
cat
healthi
suffer
diseas
antibodi
nevertheless
measur
serum
antibodi
use
guid
prevent
measur
use
fcov
control
multicat
household
antibodi
detect
perform
screen
cat
newli
integr
group
help
confirm
success
elimin
fcov
group
cat
guid
separ
infect
noninfect
cat
cat
without
detect
antibodi
like
shed
fcov
fece
howev
fecal
shed
observ
experiment
infect
cat
despit
absenc
serum
antibodi
diagnost
util
antifcov
antibodi
detect
effus
examin
studi
well
cat
fip
confirm
histopatholog
antibodi
detect
effus
sensit
specif
although
number
sound
promis
report
antibodi
detect
serum
emphas
diagnost
valu
antibodi
measur
serum
effus
similarli
low
bear
limit
addit
mention
mani
studi
antibodi
detect
effus
suffer
limit
inclus
cat
without
definit
diagnosi
fip
exampl
comparison
antibodi
detect
serum
effus
cat
clinic
suspicion
fip
reveal
good
concord
test
result
bodi
fluid
antibodi
titer
measur
effus
lower
determin
serum
cat
howev
fip
definit
confirm
cat
includ
true
studi
fip
suspect
cat
base
differ
effus
featur
case
fulfil
criteria
fip
diagnosi
given
european
advisori
board
cat
diseas
recommend
diagnosi
definit
confirm
cat
detect
antifcov
antibodi
sensit
fact
cat
without
detect
antibodi
posit
fcov
rna
effus
demonstr
antifcov
antibodi
detect
alon
limit
diagnost
valu
one
studi
even
found
invers
correl
fcov
antibodi
titer
fcov
viral
load
therefor
fals
neg
antibodi
result
occur
cat
high
viral
rna
load
conclus
antibodi
detect
effus
use
diagnosi
fip
antibodi
detect
serum
tabl
detect
antifcov
antibodi
csf
cat
neurolog
fip
first
regard
use
diagnosi
subsequ
investig
includ
larger
appropri
control
group
show
detect
antibodi
csf
serum
effus
suitabl
definit
ant
mortem
diagnosi
fip
sensit
specif
calcul
histopatholog
refer
standard
control
group
either
consist
cat
kind
neurolog
diseas
combin
cat
neurolog
nonneurolog
disord
tabl
recent
studi
includ
cat
neurolog
sign
suggest
caus
fip
although
diagnosi
confirm
histopatholog
studi
csf
larg
number
cat
analyz
reveal
low
sensit
detect
fcov
antibodi
diagnosi
fip
howev
author
hypothes
detect
fcov
rna
csf
would
confirm
fip
found
fcov
rna
cat
csf
antibodi
titer
higher
base
result
conclud
csf
antibodi
titer
higher
might
confirmatori
fip
howev
result
limit
valu
control
cat
includ
studi
diagnosi
fip
confirm
due
correl
serum
csf
antibodi
fact
antibodi
titer
measur
serum
alway
higher
measur
csf
extravas
antibodi
serum
csf
across
impair
bloodbrain
barrier
discuss
like
explan
detect
antifcov
antibodi
csf
cat
without
fip
anoth
possibl
seem
local
antibodi
product
migrat
b
lymphocyt
cat
fecv
infect
wherea
evid
specif
antibodi
product
intrathec
b
lymphocyt
product
nonprotect
antibodi
format
immun
complex
discuss
key
featur
develop
typic
immunemedi
lesion
cat
fip
circul
immun
complex
could
detect
serum
effus
fcovinfect
cat
compar
histopatholog
refer
standard
detect
immun
complex
serum
via
competit
enzymelink
immunosorb
assay
elisa
sensit
specif
diagnos
fip
tabl
control
cat
studi
suspect
fip
anoth
diseas
diagnos
investig
confirm
presenc
fcovspecif
immun
complex
healthi
cat
without
fip
suggest
also
fecvinfect
cat
immun
complex
seem
circul
although
limit
period
time
conclus
detect
immun
complex
use
diagnosi
fip
immunohistochem
stain
fcov
antigen
within
characterist
histopatholog
tissu
lesion
still
consid
gold
standard
diagnosi
fip
first
report
studi
describ
detect
fcov
antigen
epitheli
cell
cat
nictit
membran
immunofluoresc
stain
impress
smear
differ
studi
use
avidinbiotincomplex
abc
method
detect
fcov
antigen
tissu
sampl
variou
organ
enzymat
color
chang
sinc
success
immunostain
antigen
demonstr
sever
time
differ
organ
cat
indirect
immunofluoresc
immunohistochemistri
ihc
within
tissu
macrophag
histopatholog
evid
tissu
lesion
caus
fip
ihc
shown
excel
sensit
cat
histopatholog
confirm
fip
also
specif
exclud
fip
control
cat
diseas
diagnos
histopatholog
overview
studi
report
detect
fcov
antigen
tissu
sampl
shown
tabl
mani
case
ihc
perform
post
mortem
ant
mortem
tissu
sampl
collect
via
laparotomi
laparoscopi
invas
procedur
bear
sever
risk
sick
cat
mani
differ
organ
sampl
due
fact
fcov
antigen
variabl
distribut
within
fipinduc
tissu
lesion
unfortun
use
liver
kidney
lymph
node
sampl
obtain
minim
invas
ultrasoundguid
fineneedl
aspir
fna
trucut
biopsi
tcb
immunocytochem
immunohistochem
stain
shown
result
low
sensit
possibl
explan
could
inadequ
materi
obtain
analysi
due
cellular
damag
addit
fals
posit
immunocytochem
result
found
mesenter
lymph
node
sampl
result
specif
therefor
immunocytochemistri
icc
ihc
sampl
obtain
fna
tcb
reliabl
confirm
exclud
fip
sole
diagnost
test
besid
diagnost
use
ihc
also
appli
detect
fcov
antigen
macrophag
unusu
tissu
nondomest
felid
fcov
antigen
detect
skin
two
cat
atyp
skin
lesion
caus
fip
penil
tissu
male
cat
differ
tissu
obtain
mountain
lion
ocular
tissu
lion
often
immunofluoresc
stain
perform
detect
fcov
antigen
effus
fluoresceinconjug
antibodi
use
detect
fcov
antigen
within
cytoplasm
macrophag
earlier
studi
test
report
excel
specif
therefor
believ
posit
result
would
case
allow
definit
diagnosi
fip
howev
recent
investig
also
show
posit
result
immunofluoresc
icc
cat
effus
caus
diseas
fip
possibl
explan
fals
posit
result
includ
bind
antibodi
cellular
structur
within
macrophag
nonspecif
stain
system
spread
subsequ
detect
fecv
cat
without
fip
sensit
immunostain
effus
absolut
thu
neg
test
result
exclud
fip
low
number
macrophag
effus
sampl
competit
bind
fcov
antigen
circul
antibodi
effus
possibl
reason
fals
neg
result
one
studi
demonstr
cat
fals
neg
test
result
antifcov
antibodi
serum
effus
one
studi
report
sensit
detect
fcov
antigen
effus
immunofluoresc
stain
contrast
studi
examin
effus
sampl
obtain
ant
post
mortem
studi
includ
sampl
collect
ant
mortem
addit
monoclon
biotinyl
antibodi
use
wherea
previou
studi
appli
polyclon
fluoresceinconjug
antiserum
stain
protocol
final
sampl
analyz
within
hour
collect
longer
interv
sampl
analysi
could
result
decreas
sensit
decreas
sensit
could
observ
increas
time
interv
sampl
collect
analysi
although
fcov
antigen
could
still
detect
least
two
day
sampl
store
room
temperatur
tabl
show
studi
investig
detect
fcov
antigen
effus
refer
standard
either
histopatholog
andor
ihc
control
group
consist
cat
clinic
sign
consist
fip
definit
diagnosi
anoth
diseas
also
possibl
detect
fcov
antigen
csf
cat
fip
without
neurolog
sign
prospect
studi
date
report
sensit
specif
immunocytochem
demonstr
fcov
antigen
macrophag
csf
cat
without
neurolog
sign
tabl
studi
ihc
refer
standard
diagnosi
fip
control
cat
clinic
sign
typic
fip
diseas
diagnos
histopatholog
ihc
neg
cat
cat
neurolog
sign
evalu
sensit
surprisingli
decreas
wherea
specif
slightli
increas
cat
without
neurolog
sign
evalu
sensit
specif
cat
without
fip
present
effus
uveiti
common
ocular
sign
without
involv
central
nervou
system
notic
affect
cat
secondari
inflamm
ocular
structur
breakdown
bloodocular
barrier
fcovbear
macrophag
present
eye
fcov
antigen
detect
immunocytochem
within
macrophag
aqueou
humor
result
prospect
studi
evalu
icc
aqueou
humor
cat
immunohistochem
confirm
fip
control
cat
similar
clinic
sign
histopatholog
diagnos
diseas
depict
tabl
techniqu
moder
sensit
specif
diagnosi
fip
therefor
use
singl
confirm
diagnost
test
cat
fip
larg
quantiti
fcov
rna
found
tissu
inflammatori
chang
tissu
involv
diseas
process
contain
small
amount
viral
rna
among
organ
highest
viral
load
omentum
mesenter
lymph
node
spleen
tissu
use
analysi
rtpcr
kidney
liver
lung
myocardium
poplit
lymph
node
contrast
contain
littl
viral
rna
studi
use
rtpcr
target
fcov
rna
tissu
summar
tabl
howev
veterinari
practic
rtpcr
rare
appli
tissu
sampl
diagnos
fip
would
usual
requir
invas
tissu
sampl
collect
via
laparotomi
laparoscopi
done
post
mortem
therefor
studi
cite
mainli
perform
research
purpos
aim
evalu
rtpcr
tissu
sampl
diagnost
test
fip
earli
studi
appli
rtpcr
tissu
sampl
liver
kidney
andor
spleen
fcov
rna
identifi
cat
clinic
suspect
fip
experiment
infect
cat
test
posit
fcov
rtpcr
howev
fcov
rna
also
detect
tissu
cat
without
fip
indic
detect
fcov
rna
tissu
specif
fip
especi
hemolymphat
tissu
spleen
mesenter
lymph
node
bone
marrow
fcov
rna
could
detect
cat
fip
also
clinic
healthi
fecvinfect
cat
cat
fip
realtim
rtpcr
posit
spleen
case
mesenter
lymph
node
bone
marrow
case
healthi
fecvinfect
cat
fcov
rna
found
spleen
mesenter
lymph
node
bone
marrow
case
state
howev
cat
fip
usual
exhibit
higher
viral
copi
number
tissu
healthi
fecvinfect
cat
order
develop
rtpcr
assay
specif
fip
one
studi
evalu
realtim
rtpcr
detect
messeng
rna
mrna
thu
replic
viru
hypothes
rtpcr
would
detect
fipv
cat
fip
fecv
healthi
fcovinfect
cat
inde
studi
tissu
healthi
fecvinfect
cat
test
neg
fcov
mrna
case
wherea
fcov
mrna
found
tissu
cat
immunohistochem
confirm
fip
organ
highest
frequenc
harbor
fcov
mrna
cat
mesenter
lymph
node
spleen
lung
liver
bronchial
lymph
node
kidney
intestin
recent
studi
evalu
use
quantit
rtpcr
rtqpcr
detect
fcov
rna
fna
sampl
mesenter
lymph
node
abnorm
tissu
clinic
case
hypothes
techniqu
would
use
tool
diagnos
fip
veterinari
practition
especi
cat
without
effus
first
studi
includ
control
cat
either
fcov
antibodyneg
antibodyposit
without
sign
indic
fip
confirm
anoth
caus
illnessdeath
addit
cat
noneffus
fip
confirm
either
histopatholog
diagnost
algorithm
includ
cat
mesenter
lymph
node
sampl
minim
invas
ultrasoundguid
fna
examin
rtqpcr
found
detect
fcov
rna
mesenter
lymph
node
fna
sensit
specif
method
diagnos
fip
even
analyz
ship
without
preserv
although
fcov
rna
also
detect
mesenter
lymph
node
small
proport
cat
without
fip
therefor
complet
specif
fip
second
studi
retrospect
includ
eleven
cat
fip
without
effus
success
amplifi
fcov
rna
fna
sampl
variou
organ
cat
sinc
control
group
includ
studi
specif
could
evalu
find
made
studi
differ
sampl
fna
incision
biopsi
ib
obtain
differ
tissu
mesenter
poplit
lymph
node
liver
kidney
spleen
omentum
cat
immunohistochem
confirm
fip
order
determin
preval
fcov
rna
differ
tissu
potenti
evalu
diagnost
perform
rtpcr
tissu
sampl
diagnos
fip
sensit
high
tissu
except
poplit
lymph
node
sensit
greatli
differ
whether
fna
ib
use
sinc
control
group
includ
specif
could
determin
base
erron
assumpt
fipv
fecv
abl
infect
monocytesmacrophag
dissemin
system
thought
detect
fcov
rna
blood
proof
infect
fipv
thu
fip
therefor
rtpcr
initi
develop
use
primer
highli
conserv
untransl
region
utr
fcov
genom
order
detect
known
fcov
isol
result
rtpcr
could
neither
differenti
fecv
fipv
could
distinguish
fcov
ccv
tgev
nevertheless
state
assum
fipv
would
detect
blood
howev
year
shown
fcov
rna
could
also
detect
blood
asymptomat
cat
cat
diseas
fip
sever
studi
evalu
use
rtpcr
serum
plasma
whole
blood
confirm
find
possibl
fcov
viremia
cat
without
fip
addit
recent
studi
demonstr
fcov
viremia
even
predict
develop
fip
none
healthi
cat
test
posit
genom
replic
fcov
develop
fip
clinic
ill
within
six
month
test
studi
use
rtpcr
blood
sampl
summar
tabl
differ
blood
fraction
examin
sensit
specif
present
rang
studi
use
histopatholog
refer
standard
one
studi
also
use
detect
fcov
antigen
macrophag
effus
studi
limit
includ
cat
fip
suspect
clinic
diagnosi
confirm
control
group
either
consist
healthi
cat
andor
cat
diseas
fip
sometim
show
clinic
sign
consist
fip
one
addit
studi
worth
mention
shown
tabl
studi
includ
serum
sampl
cat
abdomin
clinic
sign
sinc
definit
diagnosi
establish
cat
sensit
specif
could
determin
therefor
studi
mention
tabl
nevertheless
worth
note
studi
cat
posit
result
nest
rtpcr
rtnpcr
assay
one
cat
surviv
almost
three
year
examin
four
addit
cat
live
least
month
sinc
median
surviv
time
cat
fip
short
unless
new
antivir
drug
appli
like
cat
fip
rtnpcr
fals
posit
sinc
fcov
viremia
detect
rtpcr
fecvinfect
cat
without
fip
detect
fcov
rna
blood
specif
fip
rtpcr
blood
sampl
use
confirm
diagnosi
fip
addit
fcov
viral
load
low
blood
fraction
experiment
fip
like
also
case
natur
infect
lead
rather
low
sensit
rtpcr
blood
rtpcr
better
sensit
peripher
blood
mononuclear
cell
pbmc
use
compar
serum
howev
studi
came
differ
result
regard
sensit
differ
blood
fraction
studi
well
compar
sensit
poor
studi
therefor
due
rather
low
viru
load
result
low
sensit
blood
sampl
recommend
analysi
rtpcr
although
fecv
infect
monocyt
macrophag
capabl
effici
replic
within
attempt
increas
specif
rna
detect
blood
rtpcr
specif
amplifi
fcov
mrna
develop
order
detect
activ
replic
viru
blood
initi
studi
rtpcr
assay
realli
detect
fcov
mrna
control
cat
clinic
sign
indic
fip
confirm
diseas
wherea
fcov
mrna
found
cat
histopatholog
confirm
fip
nevertheless
subsequ
studi
also
identifi
fcov
mrna
thu
replic
fcov
blood
sampl
healthi
cat
detect
replic
viru
predispos
develop
fip
therefor
special
rtpcr
assay
also
adequ
specif
fip
gener
howev
cat
fip
exhibit
higher
viral
load
copi
number
healthi
fecvinfect
cat
higher
viral
copi
number
found
fece
healthi
fecvinfect
cat
compar
blood
therefor
rtpcr
allow
simultan
amplif
quantif
viral
mrna
could
potenti
distinguish
fecv
low
viral
copi
number
fipv
high
viral
copi
number
realtim
rtpcr
base
primerprob
energi
transfer
detect
quantifi
subgenom
fcov
mrna
show
good
sensit
specif
one
studi
far
appli
small
number
sampl
use
field
loopmedi
isotherm
amplif
lamp
new
molecular
method
advantag
deliv
rapid
inhous
test
result
revers
transcriptas
lamp
rtlamp
use
amplifi
fcov
rna
blood
effus
lymph
node
fece
cat
suspect
fip
recent
studi
rtnpcr
use
refer
standard
specif
rtlamp
materi
sensit
howev
low
moder
cat
fip
effus
viru
load
much
higher
effus
blood
sensit
specif
rtpcr
assay
diagnosi
fip
effus
list
tabl
shown
sampl
number
rel
low
especi
older
studi
studi
use
histopatholog
refer
standard
studi
detect
fcov
antigen
effus
tissu
laboratori
fluid
analysi
refer
standard
one
studi
includ
cat
suspicion
fip
histopatholog
confirm
diseas
cat
effus
anoth
studi
examin
effus
sampl
cat
suspect
fip
base
effus
featur
criteria
establish
european
advisori
board
cat
diseas
diagnosi
howev
confirm
refer
standard
method
cat
control
group
consist
cat
clinic
suspicion
fip
differ
diagnos
one
studi
examin
larg
number
effus
sampl
cat
clinic
suspect
fip
diseas
howev
confirm
could
also
determin
whether
cat
neg
rtpcr
result
diseas
fip
therefor
sensit
specif
could
calcul
fcov
rna
detect
effus
cat
anoth
studi
plasma
andor
ascit
cat
histopatholog
confirm
fip
control
healthi
fiptyp
clinic
sign
diseas
examin
rtnpcr
fcov
rna
detect
plasma
cat
fip
five
addit
cat
test
neg
plasma
posit
rtnpcr
result
effus
howev
state
mani
effus
sampl
analyz
total
thu
studi
includ
tabl
although
specif
rtpcr
effus
high
mani
studi
posit
rtpcr
result
add
suspicion
fip
kept
mind
rtpcr
alreadi
detect
small
amount
viral
rna
potenti
leak
blood
effus
face
inflamm
even
without
fip
cat
circul
fecv
especi
recent
studi
fcov
rna
could
also
detect
effus
cat
without
fip
studi
evalu
rtpcr
detect
fcov
rna
csf
report
specif
mean
fcov
rna
could
detect
csf
cat
fip
without
neurolog
sign
control
cat
tabl
refer
standard
use
studi
either
histopatholog
andor
detect
fcov
antigen
effus
tissu
control
group
consist
cat
neurolog
diseas
also
includ
cat
nonneurolog
diseas
clinic
sign
consist
fip
although
bloodbrain
barrier
specif
examin
cat
fip
yet
assum
impair
secondari
inflamm
caus
fip
gener
variou
infecti
inflammatori
diseas
central
nervou
system
lead
releas
cytokin
adhes
molecul
metalloproteas
mediat
damag
tight
junction
basal
membran
cerebrovascular
endothelium
enabl
leakag
cell
pathogen
csf
across
bloodbrain
barrier
therefor
although
fals
posit
rtpcr
result
report
csf
thu
far
seem
theoret
possibl
fecv
could
pass
bloodbrain
barrier
cat
neurolog
diseas
fip
also
suspect
antifcov
antibodi
one
studi
detect
correl
high
antifcov
antibodi
posit
rtpcr
csf
studi
fcov
rna
found
sampl
cat
low
sampl
cat
high
csf
antibodi
titer
contrast
fcov
rna
amplifi
antibodyneg
cat
howev
fip
confirm
cat
studi
anoth
type
sampl
materi
examin
fcov
rna
rtpcr
aqueou
humor
date
studi
evalu
sampl
materi
analysi
rtpcr
small
number
cat
fip
tabl
addit
case
report
demonstr
posit
rtpcr
aqueou
humor
cat
uveiti
howev
cleardefin
fip
control
group
first
studi
provid
evid
associ
two
gene
mutat
fip
number
studi
subsequ
investig
preval
mutat
tissu
sampl
cat
without
fip
tabl
opinion
vari
substanti
among
research
especi
specif
gene
mutat
fip
phenotyp
exampl
one
recent
studi
corrobor
initi
find
detect
three
tissu
sampl
mesenteri
colon
lymph
node
omentum
cat
fip
moreov
mutat
fulli
discrimin
fcov
found
tissu
sampl
fcov
found
fecal
sampl
healthi
cat
contrast
fcov
substitut
specif
fip
phenotyp
differ
studi
also
found
mutat
tissu
sampl
cat
without
fip
major
fcov
tissu
sampl
cat
fip
also
major
tissu
sampl
control
cat
without
fip
leucin
thu
mutat
sequenc
posit
studi
hand
major
fcov
fecal
sampl
cat
without
fip
methionin
thu
nonmut
sequenc
posit
addit
number
tissu
sampl
cat
fip
also
exhibit
methionin
posit
mean
contain
mutat
despit
cat
fip
therefor
author
conclud
substitut
indic
system
spread
fcov
rather
marker
fip
studi
five
tissu
sampl
contain
substitut
analyz
substitut
less
common
gene
mutat
sanger
sequenc
detect
sampl
cat
fip
one
remain
sampl
control
cat
sinc
first
descript
pcr
assay
detect
mutat
frequent
use
diagnost
purpos
number
studi
evalu
sensit
specif
diagnost
accuraci
detect
mutat
diagnosi
fip
tabl
howev
larg
contrast
result
also
found
studi
especi
term
specif
possibl
result
differ
sequenc
assay
use
one
studi
exampl
examin
larg
number
tissu
fluid
fecal
sampl
cat
immunohistochem
confirm
fip
control
fip
exclud
perform
rtqpcr
follow
pyrosequenc
gene
amplicon
rtqpcrposit
sampl
total
tissu
sampl
cat
fip
analyz
howev
sinc
histopatholog
data
avail
tissu
sampl
number
includ
calcul
sensit
specif
tabl
sampl
rtqpcrposit
gene
mutat
detect
sampl
much
common
mix
mutat
nonmut
fcov
fcov
also
present
tissu
sampl
control
cat
rtqpcrposit
posit
mutat
compar
sensit
specif
rtqpcr
alon
rtqpcr
plu
gene
sequenc
specif
slightli
increas
wherea
sensit
decreas
therefor
conclud
detect
fcov
gene
mutat
improv
abil
diagnos
fip
mutat
also
found
cat
without
fip
support
hypothesi
mutat
marker
system
spread
fcov
fip
somewhat
similar
result
obtain
year
later
studi
compar
differ
laboratori
test
tissu
sampl
mesenter
lymph
node
spleen
small
intestin
lung
cat
fip
posit
ihc
least
one
tissu
control
cat
histopatholog
diagnosi
anoth
diseas
plu
neg
ihc
sampl
examin
rtnpcr
target
highli
conserv
utr
sequenc
perform
detect
gene
mutat
detect
fcov
gene
mutat
improv
specif
rtnpcr
sensit
decreas
gene
mutat
type
mutat
shown
also
detect
cat
without
fip
howev
contrast
result
obtain
realtim
rtpcr
develop
evalu
subsequ
use
specif
fluoresc
hydrolysi
probe
detect
either
one
two
snp
wildtyp
sequenc
studi
none
cat
without
fip
histopatholog
diagnosi
plu
neg
ihc
test
posit
one
gene
mutat
tissu
cat
immunohistochem
confirm
fip
test
posit
one
gene
mutat
least
one
tissu
one
mix
genotyp
studi
sensit
compar
previou
studi
howev
specif
excel
final
recent
studi
evalu
realtim
rtpcr
detect
gene
mutat
cat
immunohistochem
confirm
fip
fna
ib
sampl
obtain
mesenter
poplit
lymph
node
spleen
liver
kidney
omentum
addit
differ
bodi
fluid
sampl
first
examin
rtpcr
detect
fcov
gene
detect
fcov
rtpcrposit
sampl
subsequ
analyz
realtim
rtpcr
detect
gene
mutat
interestingli
fcov
gene
mutat
present
everi
cat
locat
mutat
fcov
vari
cat
cat
sensit
rtpcr
detect
fcov
good
tissu
except
poplit
lymph
node
sensit
decreas
gene
mutat
evalu
sinc
sensit
fna
ib
significantli
differ
sampl
via
minim
invas
fna
seem
possibl
order
obtain
adequ
sampl
rtpcr
test
specif
determin
studi
sinc
control
group
includ
studi
protocol
diagnost
accuraci
detect
fcov
gene
mutat
also
evalu
blood
sampl
tabl
rtnpcr
subsequ
gene
sequenc
serum
plasma
sampl
cat
fip
diagnos
histopatholog
ihc
posit
immunofluoresc
effus
control
cat
diagnos
anoth
diseas
either
ant
post
mortem
reveal
sensit
confirm
low
viru
load
blood
rtnpcr
neg
blood
sampl
cat
without
fip
thu
specif
sequenc
step
could
determin
subsequ
studi
evalu
aforement
realtim
rtpcr
detect
gene
mutat
specif
fluoresc
hydrolysi
probe
blood
sampl
plasma
serum
buffi
coat
whole
blood
cat
fip
andor
control
refer
standard
histopatholog
ihc
either
detect
mutat
fcov
blood
sampl
found
low
sensit
cat
fip
fcov
rna
detect
viral
concentr
low
allow
pathotyp
implic
blood
recommend
sampl
materi
nevertheless
studi
compar
differ
pcr
test
includ
utr
rtnpcr
combin
approach
rtpcr
follow
gene
sequenc
report
sensit
rtnpcr
combin
rtpcr
sequenc
whole
blood
use
potenti
whole
blood
give
better
result
plasma
serum
although
author
state
specif
rtnpcr
combin
approach
specif
sequenc
step
calcul
studi
sinc
none
blood
sampl
cat
without
fip
test
posit
fcov
rna
associ
substitut
fip
shown
studi
detect
amino
acid
substitut
fcov
extract
ascit
cat
fip
refer
standard
diagnosi
report
nonmut
sequenc
methionin
codon
fcov
extract
fece
healthi
cat
fcov
extract
fece
cat
fip
howev
contrast
result
pcr
assay
detect
fcov
gene
mutat
tissu
blood
found
subsequ
analyz
effus
fluid
sampl
diagnost
purpos
tabl
one
studi
includ
cat
fip
confirm
ihc
control
cat
classifi
nonfip
confirm
diseas
base
either
histopatholog
andor
definit
diagnosi
anoth
diseas
ant
mortem
show
rtqpcr
alon
sensit
specif
rtqpcrposit
cat
mutat
fcov
substitut
effus
detect
sequenc
one
cat
exhibit
mutat
result
sensit
detect
gene
mutat
sinc
none
control
cat
rtqpcr
posit
specif
sequenc
step
could
determin
thu
major
effus
sampl
gener
sequenc
data
contain
mutat
fcov
although
studi
popul
detect
gene
mutat
improv
specif
rtnpcr
subsequ
gene
sequenc
use
effus
sampl
cat
fip
diagnos
histopatholog
ihc
posit
immunofluoresc
effus
control
cat
diagnos
anoth
diseas
either
ant
post
mortem
similarli
moder
sensit
detect
sampl
cat
fip
rtnpcrposit
major
contain
gene
mutat
n
n
rtnpcr
neg
effus
sampl
cat
without
fip
thu
specif
sequenc
step
could
determin
evalu
realtim
rtpcr
detect
gene
mutat
specif
fluoresc
hydrolysi
probe
effus
cat
fip
control
refer
standard
histopatholog
ihc
detect
similar
sensit
detect
gene
mutat
sampl
cat
fip
one
studi
rtpcrposit
mutat
fcov
contain
detect
major
sampl
addit
mix
fcov
without
gene
mutat
detect
two
cat
cat
rtpcr
posit
rtpcr
detect
gene
mutat
success
either
low
viru
load
n
despit
high
viru
load
n
reason
latter
could
presenc
unknown
sequenc
variat
serotyp
ii
fcov
rtpcr
also
posit
effus
sampl
cat
without
fip
detect
one
ascit
sampl
cat
chronic
kidney
diseas
final
one
recent
studi
collect
differ
bodi
fluid
csf
aqueou
humor
ascit
pleural
pericardi
effus
cat
fip
confirm
ihc
cat
histopatholog
sign
fip
absent
sampl
cat
fip
rtqpcrposit
subsequ
pyrosequenc
step
one
sampl
lost
gene
analysi
contain
mutat
fcov
n
n
mix
mutat
nonmut
fcov
without
differenti
mutat
n
fluid
sampl
cat
without
fip
one
rtqpcrposit
contain
substitut
abdomin
fluid
sampl
cat
necrot
pneumonia
sinc
individu
result
effus
csf
aqueou
humor
shown
studi
sensit
specif
calcul
individu
fluid
sampl
togeth
tabl
demonstr
tissu
sampl
detect
gene
mutat
studi
led
decreas
sensit
rtqpcr
alon
compar
combin
approach
gene
mutat
also
detect
cat
without
fip
detect
fcov
gene
mutat
csf
evalu
two
studi
present
confer
abstract
thu
far
tabl
one
studi
obtain
csf
sampl
cat
fip
confirm
ihc
report
sensit
control
cat
includ
studi
studi
look
cat
immunohistochem
confirm
fip
six
neurolog
sign
control
cat
clinic
sign
indic
fip
neurolog
sign
definit
diagnos
diseas
calcul
sensit
sensit
increas
cat
neurolog
sign
includ
sinc
fcov
rna
detect
control
cat
specif
detect
gene
mutat
could
calcul
two
studi
present
confer
abstract
evalu
sensit
specif
detect
fcov
gene
mutat
aqueou
humor
tabl
studi
includ
cat
fip
confirm
ihc
report
sensit
specif
howev
could
calcul
either
one
studi
either
control
cat
includ
none
control
cat
fcovposit
ant
mortem
diagnosi
fip
made
base
result
one
singl
diagnost
test
import
consid
signal
histori
clinic
sign
standard
clinicopatholog
abnorm
everi
cat
present
suspicion
fip
addit
test
especi
test
direct
viru
detect
util
depend
clinic
pictur
measur
fcov
antibodi
use
diagnosi
routin
hematolog
serum
biochemistri
present
analysi
effus
perform
everi
cat
cat
neurolog
clinic
sign
csf
analysi
done
well
diagnost
tree
depict
relev
addit
diagnost
step
recommend
depend
cat
clinic
present
shown
figur
cat
effus
laboratori
analysi
fluid
includ
rivalta
test
perform
test
neg
fip
rather
unlik
especi
pretest
probabl
fip
low
rivalta
test
posit
howev
diagnost
step
follow
rtpcr
effus
help
establish
diagnosi
especi
viral
copi
number
high
neg
rtpcr
effus
make
fip
unlik
unless
suspicion
high
base
clinic
find
laboratori
test
result
high
fcov
load
detect
gene
mutat
rtpcrposit
effus
sampl
substanti
suspicion
fip
addit
order
increas
sensit
detect
gene
mutat
sampl
materi
fna
mesenter
lymph
node
spleen
liver
whole
blood
includ
analysi
howev
gene
mutat
detect
rtpcrposit
sampl
viru
load
low
still
suspicion
fip
high
case
invas
diagnost
procedur
histopatholog
ihc
tissu
sampl
obtain
laparotomylaparoscopi
consid
order
confirm
exclud
fip
cat
present
without
signific
effus
analysi
differ
sampl
type
combin
ultrasoundguid
fna
differ
organ
includ
mesenter
lymph
node
spleen
liver
provid
sampl
materi
gener
rtpcr
first
diagnost
test
case
cat
neurolog
clinic
sign
diagnost
imag
csf
sampl
import
step
reach
diagnosi
anyway
csf
submit
rtpcr
well
true
cat
uveiti
aqueou
humor
integr
set
differ
sampl
analysi
rtpcr
test
sever
materi
sensit
given
test
increas
gener
rtpcr
posit
cat
without
effus
presenc
fcov
gene
mutat
high
fcov
load
might
aid
case
mutat
detect
rtpcrposit
sampl
especi
copi
number
pretest
probabl
fip
high
fip
like
howev
gene
mutat
detect
set
sampl
gener
rtpcr
sampl
submit
neg
viru
load
low
caus
fip
rule
far
possibl
suspicion
fip
still
high
base
signal
clinic
laboratori
find
case
neg
rtpcr
case
lack
gene
mutat
histopatholog
ihc
tissu
sampl
must
consid
order
reach
definit
diagnosi
howev
long
uncertainti
regard
put
role
gene
mutat
fip
pathogenesi
sinc
specif
rtpcr
given
sampl
absolut
ideal
diagnost
test
fip
still
exist
ihc
histopatholog
abnorm
tissu
obtain
either
post
mortem
via
laparotomylaparoscopi
still
remain
gold
standard
diagnosi
